BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 7256544)

  • 1. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.
    Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW
    Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation.
    Antrum RM; Solomkin JS
    Surgery; 1986 Jul; 100(1):29-37. PubMed ID: 3726758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of loss of human neutrophil chemotaxis following thermal injury.
    Nelson RD; Hasslen SR; Ahrenholz DH; Solem LD
    J Burn Care Rehabil; 1987; 8(6):496-502. PubMed ID: 3436972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.
    Patrick RA; Hollers JC; Liu DY; Giese BH; Smith CW
    Infect Immun; 1980 Jun; 28(3):700-7. PubMed ID: 7399690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil heterogeneity in patients with blunt trauma.
    Krause PJ; Maderazo EG; Bannon P; Kosciol K; Malech HM
    J Lab Clin Med; 1988 Aug; 112(2):208-15. PubMed ID: 3397624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxy radical as autotoxin in chemotactically activated neutrophils.
    Till GO; Lutz MJ; Ward PA
    Biomed Pharmacother; 1987; 41(6):349-54. PubMed ID: 2833323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.